Novel PET agent targets copper in prostate tumors
Italian researchers are reporting progress with a novel PET imaging agent that...Read more on AuntMinnie.comRelated Reading: PSMA-PET/CT helps spot early prostate cancer recurrence SNMMI: PET/CT with prostate agent changes therapy plans SNMMI: PET/CT may help guide prostate biopsies New PET tracer aids in metastatic prostate cancer PET tracer boosts detection of recurrent prostate cancer
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Shared decision making is recommended regarding prostate cancer screening. Decision aids may facilitate this process; however, the impact of decision aids on screening preferences is poorly understood.
AbstractPurpose of reviewThe introduction of antiretroviral therapy (ART) has revolutionized HIV infection management, resulting in improved outcomes and survival for people living with HIV (PLWH). However, as PLWH are living longer and aging, non-AIDS-defining cancers (NADCs) represent a significant source of morbidity and mortality in the HIV-infected population. Here, we review the epidemiology of NADCs in PLWH.Recent findingsCancer mortality among PLWH is much higher than that among the general population. Up to 10% of deaths among PLWH have been attributed to NADCs. Furthermore, PLWH have an increased risk for specifi...
Researchers are developing a PET radiotracer designed to adhere to and illuminate...Read more on AuntMinnie.comRelated Reading: MRI holds promise for immunotherapy but needs more research Novel PET tracer could identify bacterial infections Immuno-PET radiotracers may aid cancer treatment Novel PET tracer aids recurrent prostate cancer patients Radiation, immunotherapy form best team against melanoma
Conclusion: The cancer burden among PLWH is projected to shift, with prostate and lung cancer expected to emerge as the most common types by 2030. Cancer will remain an important comorbid condition, and expanded access to HIV therapies and cancer prevention, screening, and treatment is needed. Primary Funding Source: National Cancer Institute. PMID: 29801099 [PubMed - as supplied by publisher]
CONCLUSION: There are several essential strategies for increasing African-American men's participation in health research: ensuring the research team is culturally and gender-sensitive; recruiting in trusted environments; using respected gatekeepers; developing trust with participants; and being transparent. IMPLICATIONS FOR PRACTICE: Implementing strategies to include African-American men in health research has the potential to improve health disparities in the US. PMID: 29738190 [PubMed - as supplied by publisher]
(MedPage Today) -- Model predicts decline AIDS-defining cancers; uptick in lung, prostate cancers
TUESDAY, April 10, 2018 -- Men on androgen-deprivation therapy (ADT) for prostate cancer may significantly benefit from a group exercise and nutrition program, according to a study published online March 5 in the Annals of Behavioral Medicine. Brian...
Radical prostatectomy (RP) leaves 45-75% of patients with long-term sexual dysfunction (SD). Approximately 60% of patients report significant emotional distress related to their SD that may progress to maladjustment in their relationships with partners. Despite high levels of effectiveness, 30-50% of patients who turn to sexually assistive aids after RP discontinue use of the aids within one year. The available research exploring this gap between effectiveness and ongoing use supports a broader perspective of SD that includes psychological, behavioural, social and interpersonal factors.
Prostate cancer screening decision is preference-sensitive. Decision aids may facilitate screening decision by providing information on the risks and benefits of screening. We conducted a systematic review and meta-analysis of RCTs that addressed the impact of decision aids on decisional outcomes and the men's screening decision.